^
BIOMARKER:

RAS mutation





Show legend

Include preclinical:
Colorectal Cancer
Thyroid Gland Medullary Carcinoma
Rectal Cancer
Acute Myelogenous Leukemia
Hematological Malignancies
Multiple Myeloma
Thyroid Gland Anaplastic Carcinoma
Thyroid Gland Carcinoma
Rhabdomyosarcoma
Pancreatic Ductal Adenocarcinoma
cabozantinib capsule
trametinib
bevacizumab + sintilimab
binimetinib
selinexor
sorafenib
EGFR inhibitor
atezolizumab + cobimetinib
pembrolizumab + selinexor
venetoclax
regorafenib
SOXIRI
FOLFOXIRI
durvalumab + tremelimumab
mTOR inhibitor
IMM-6-415
cetuximab
bevacizumab
trametinib + AMG 479